Detalhe da pesquisa
1.
IL-1ß+ macrophages fuel pathogenic inflammation in pancreatic cancer.
Nature
; 623(7986): 415-422, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37914939
2.
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer.
Molecules
; 26(6)2021 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33804240
3.
PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer.
J Exp Clin Cancer Res
; 43(1): 157, 2024 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38824552
4.
HLA-DPB1*13:01 associates with enhanced, and KIR2DS4*001 with diminished protection from developing severe COVID-19.
HLA
; 103(1): e15251, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37850268
5.
Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival.
Clin Exp Med
; 23(8): 5089-5100, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37910256
6.
The dark side of immunotherapy: pancreatic cancer.
Cancer Drug Resist
; 3(3): 491-520, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-35582441